Clinical trial
COGNIShunt® System for Alzheimer's Disease
NCT00056628 · Eunoe, Industry · Completed
Key facts
| NCT number | NCT00056628 |
|---|---|
| Title | COGNIShunt® System for Alzheimer's Disease |
| Official title | Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System |
| Lead sponsor | Eunoe, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Device |
| Interventions | The COGNIShunt® System |
| Enrollment | 250 |
| Start date | Jan 1, 2001 |
| Completion | Oct 1, 2004 |
| First posted | Mar 20, 2003 |
| Last update posted | Sep 12, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: